HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
about
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancerPathophysiological Basis for the Formation of the Tumor MicroenvironmentCurrent relevance of hypoxia in head and neck cancerCycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseClinical biomarkers for hypoxia targetingAcute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.Physiological and pathological responses to hypoxia.5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.Akt/hypoxia-inducible factor-1α signaling deficiency compromises skin wound healing in a type 1 diabetes mouse modelDetailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions.EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvateThe effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model.Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomasHypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia.Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factorsIs Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.HIF-α Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression.Prognostic value of HIF-1α expression during fractionated irradiation.Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cellsIncrease in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level.Hypoxic changes in the central nervous system of noise-exposed mice.The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.Hypoxia-Inducible Factor 1-Alpha Regulates Cancer-Inhibitory Effect of Human Mesenchymal Stem Cells.Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.Joint immobilization induced hypoxic and inflammatory conditions in rat knee joints.Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers.
P2860
Q21142766-5246C7B6-EE2F-4BF2-9C95-BD26FABE4553Q25256988-0164D036-97A3-4931-B719-DC6A38D14707Q26752406-37EBDE17-0C4D-42F8-AE75-9AD6DD52EE34Q28074577-8FE5D645-D3C0-4F8F-9845-D7F91ACDE2F4Q30573416-4C9B6EB7-7A5E-4140-B900-EB1E83FA5697Q33714638-1797B06A-AA76-4E1F-AA87-50FF948B788BQ34210210-5797C39F-A870-4AD8-AED2-8A995C4D0172Q34249620-8518AF08-DA9B-447A-868C-1AF3B7BDA9CBQ34322819-5B823E06-E88E-4BB8-9EFC-7748951F8DF7Q35070875-4BA0106F-1E8F-4BB9-9F3A-C1DD0083C7E8Q35758205-264A2B58-D53C-4168-9425-6212EF3BAA53Q35789454-1090CA4F-9EE6-4848-8A96-577E7A5B54CBQ36342034-0B35E1CE-9E26-4834-AE1F-9A8950C37D19Q36613531-4E4ACD39-FB3F-4B65-951C-CB718B66FA68Q36671784-27D03431-F35F-4B68-BE35-86E7DDF556F5Q36694582-812CD04B-A836-43C7-9C72-D4B4054B97ADQ36780416-32B9EF84-3EDD-41E4-8219-B7D670D0AF09Q36807138-153BE216-C7C4-474A-9D6D-6698028200E5Q37068806-DB502FE7-8F12-4F18-BBDE-9D8C54E83399Q37426436-451DFE37-6A06-400F-96C6-13A4FF3FEB6DQ37491250-F671BC8F-1F5D-47A6-A2DD-236E7FD18642Q37704374-AAD51DA3-4CF3-419F-8635-7DD9E064D572Q38002028-DB448C9D-450F-44FE-9C50-88AD49EDA4EAQ38799258-9F03355C-15D1-470C-9A50-4711C24EACC6Q38919044-0957BC2B-467D-4C63-BB7F-78C0EB33338EQ39262531-76EE79BB-B5FD-4749-AB5D-EA001428A1F5Q39628644-43D48176-77FC-4B56-821D-69924224A1C3Q39880707-F229F7DB-9C8C-426B-A768-9BB427CB6439Q40223437-200D8632-7C04-469B-BE04-44258FC10F33Q40359398-754627B6-CBF0-4D1F-9EC9-6301A6A0673BQ41103222-BEA7C0AA-21A3-4CEB-A5C3-2A572D3B1B5BQ46991063-73F884A8-2363-4AB3-AF0F-9B3616CC4E42Q51628396-C852EB9A-3797-45F1-9A5C-71DD133EBB53Q51668566-D0A9CEEA-E021-4E59-ADCD-74A7350CBE55Q51791167-3455246B-B664-45E2-AD3F-837B08A9166DQ54268257-F02DDE81-8F1A-48A0-8768-80C39A3307FFQ55442510-34E36F33-8B3D-4475-B6B6-4AD11425DC9A
P2860
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@en
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@nl
type
label
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@en
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@nl
prefLabel
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@en
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@nl
P2093
P1476
HIF-1A, pimonidazole, and iodo ...... in human head-and-neck tumors.
@en
P2093
Adrian C Begg
Alfons J Balm
Debbie Sprong
Elke Blijweert
Frank J Hoebers
Gerard Blommestijn
Hilde L K Janssen
Ingrid Hofland
James A Raleigh
Karin M G Haustermans
P304
P356
10.1016/S0360-3016(02)03935-4
P407
P577
2002-12-01T00:00:00Z